As GLP-1 Use Expands Into Dermatology, So Do the Medicolegal Implications
(MedPage Today) -- Medical liability cases involving GLP-1 receptor agonist use in dermatology have occurred infrequently to date but warrant careful attention as the use increases, a medicolegal review suggests. A review of the LexisNexis legal...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.